Case number 1:21-cv-01485
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Lupin Ltd. et al. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 19, 2023 | 31 | CONSENT JUDGMENT as to Laurus Labs Ltd. and Laurus Generics, Inc. by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. Party Laurus Generics Inc. and Laurus Labs Ltd. terminated. Signed by Judge Colm F. Connolly on 5/18/2023. (nmf) (Entered: 05/19/2023) (4) |
| May 17, 2023 | 30 | PROPOSED CONSENT JUDGMENT as to Laurus Labs Ltd. and Laurus Generics, Inc. by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) (Entered: 05/17/2023) (4) |
| Feb 14, 2023 | 29 | CONSENT JUDGMENT Between Boehringer and Mankind and LifeStar Defendants by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. Party Lifestar Pharma LLC and Party Mankind Pharma Ltd. terminated. Signed by Judge Colm F. Connolly on 2/14/2023. (nmf) (Entered: 02/14/2023) (6) |
| Feb 14, 2023 | 28 | PROPOSED CONSENT JUDGMENT Between Boehringer and Mankind and LifeStar Defendants by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) (Entered: 02/14/2023) (6) |
| Dec 12, 2022 | 27 | CONSENT JUDGMENT, Party Aurobindo Pharma USA, Inc. and Aurobindo Pharma Ltd. terminated. Signed by Judge Colm F. Connolly on 12/12/2022. (nmf) (Entered: 12/12/2022) (6) |
| Dec 9, 2022 | 26 | PROPOSED CONSENT JUDGMENT Between Boehringer and the Aurobindo Defendants by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) (Entered: 12/09/2022) (6) |
| Oct 18, 2022 | 25 | SO ORDERED, re (13 in 1:22-cv-01102-CFC) STIPULATION and Order to Consolidate and Stay Proceedings. 1. This case is hereby CONSOLIDATED with the Lead Case, 21-cv-1485-CFC; and 2. Consistent with that consolidation, this case is STAYED pending resolution of a motion to be filed by Defendants regarding the enforceability of the '323 Patent. Signed by Judge Colm F. Connolly on 10/18/2022. (nmf) (Entered: 10/18/2022) (3) |
| Sep 14, 2022 | 24 | NOTICE requesting Clerk to remove Michael K. Nutter as co-counsel. Reason for request: No longer affiliated with the case. (Bilson, David) (Entered: 09/14/2022) (1) |
| Aug 10, 2022 | 23 | NOTICE of Appearance by Alexis Stombaugh on behalf of Laurus Generics Inc., Laurus Labs Ltd. (Stombaugh, Alexis) (Entered: 08/10/2022) (3) |
| Jul 25, 2022 | 22 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove Jason Z. Pesick as co-counsel. Reason for request: No Longer with Winston & Strawn LLP. (Bilson, David) |
| Jun 14, 2022 | 21 | Letter (4) Docket Text: Letter to The Honorable Colm F. Connolly from John C. Phillips, Jr. regarding joint letter regarding discovery dispute. (Phillips, John) |
| Apr 18, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: Civil Action Nos. 21-1485, 21-1486, 21-1487, 21-1573, 21-1766 and 22-220 are consolidated for all purposes. All future filings shall be made in Lead Case No. 21-1485-CFC only. Ordered by Judge Colm F. Connolly on 4/18/2022. Associated Cases: 1:21-cv-01485-CFC et al.(nmf) |
| Apr 13, 2022 | N/A | Status Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - In-Person Status Conference held on 4/13/2022. (Court Reporter Bonnie Archer.) Associated Cases: 1:18-cv-01689-CFC-SRF et al.(nmf) |
| Apr 11, 2022 | 20 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Lina Genovesi, PhD.,Esq. - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Connolly, Arthur) |
| Apr 11, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Lina Genovesi for Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Apr 11, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [20] MOTION for Pro Hac Vice Appearance of Attorney Lina Genovesi, PhD.,Esq., filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd. Ordered by Judge Colm F. Connolly on 4/11/2022. (kmd) |
| Apr 7, 2022 | 19 | Motion for Leave to Appear Pro Hac Vice (12) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Bryan S. Hales, Jeanna M. Wacker, Sam Kwon, and Ashley Ross - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Apr 7, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (19 in 1:21-cv-01486-CFC, 29 in 1:21-cv-00530-CFC, 11 in 1:22-cv-00220-CFC, 21 in 1:21-cv-01766-CFC, 19 in 1:21-cv-01573-CFC, 19 in 1:21-cv-01485-CFC, 19 in 1:21-cv-01487-CFC) MOTION for Pro Hac Vice Appearance of Attorney Bryan S. Hales, Jeanna M. Wacker, Sam Kwon, and Ashley Ross, filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Ordered by Judge Colm F. Connolly on 4/7/2022. Associated Cases: 1:21-cv-00530-CFC et al.(kmd) |
| Apr 5, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER Re-Setting Hearings, Due to a conflict in the Court's schedule, the In-Person Status Conference to discuss the parties' letters is rescheduled for 4/13/2022 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly.) Ordered by Judge Colm F. Connolly on 4/5/2022. Associated Cases: 1:21-cv-00530-CFC et al.(nmf) |
| Apr 1, 2022 | 18 | Order (4) Docket Text: ORDER, Setting Hearings: A Status Conference is set for 4/13/2022 at 11:00 AM in Courtroom 4B before Judge Colm F. Connolly to discuss the parties' letters. Signed by Judge Colm F. Connolly on 4/1/2022. Associated Cases: 1:21-cv-00530-CFC et al.(nmf) |
| Mar 17, 2022 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pdf of the 3/15/2022 Letter to Honorable Colm F. Connolly from Megan E. Dellinger regarding response to Defendants March 11, 2022 letter has been replaced with a corrected version in order to to correct an error in the table on page 2 with respect to the answer date for defendant Laurus in the 22-220 action per request of filer. Associated Cases: 1:21-cv-00530-CFC et al.(nmf) |
| Mar 15, 2022 | 17 | Letter (4) Docket Text: Letter to Honorable Colm F. Connolly from Megan E. Dellinger regarding response to Defendants March 11, 2022 letter - re (25 in 1:21-cv-00530-CFC) Letter. (Dellinger, Megan) (Main Document 17 replaced on 3/17/2022) (nmf, ). |
| Mar 11, 2022 | 16 | Letter (4) Docket Text: Letter to The Honorable Colm F. Connolly from John C. Phillips, Jr. regarding case management issues. (Phillips, John) |
| Mar 8, 2022 | 15 | Letter (2) Docket Text: Letter to The Honorable Colm F. Connolly from Megan E. Dellinger regarding coordinated discovery and Markman - re (11 in 1:21-cv-01487-CFC, 11 in 1:21-cv-01487-CFC, 19 in 1:21-cv-00530-CFC, 19 in 1:21-cv-00530-CFC, 11 in 1:21-cv-01766-CFC, 11 in 1:21-cv-01766-CFC, 11 in 1:21-cv-01486-CFC, 11 in 1:21-cv-01486-CFC, 13 in 1:21-cv-01485-CFC, 13 in 1:21-cv-01485-CFC) Order,, Set Deadlines,. (Dellinger, Megan) |
| Feb 8, 2022 | 14 | Answer to Counterclaim (16) Docket Text: ANSWER to [11] Answer to Complaint,, Counterclaim, -- Answer to Counterclaims -- by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Feb 8, 2022 | 13 | Order (4) Docket Text: ORDER: IT IS ORDERED that, on or before March 8, 2022, counsel for plaintiffs shall inform the court as to whether the need for coordinated discovery and/or Markman proceedings is anticipated as to the above cases and, if so, when a joint scheduling conference might most efficiently be conducted. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 3/8/2022.) Signed by Judge Colm F. Connolly on 2/7/2022. Associated Cases: 1:21-cv-00530-CFC et al.(nmf) |
| Jan 18, 2022 | 12 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Connolly, Arthur) |
| Jan 18, 2022 | 11 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd..(Connolly, Arthur) |
| Dec 1, 2021 | 10 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Answer, Move, or Otherwise Respond to the Complaint to January 18, 2022 - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Connolly, Arthur) |
| Dec 1, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [10] STIPULATION TO EXTEND TIME to Answer, Move, or Otherwise Respond to the Complaint to January 18, 2022, filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd. Reset Answer Deadlines: Aurobindo Pharma Ltd. answer due 1/18/2022; Aurobindo Pharma USA, Inc. answer due 1/18/2022. Ordered by Judge Colm F. Connolly on 12/1/2021. (kmd) |
| Nov 10, 2021 | 9 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. Aurobindo Pharma USA, Inc. served on 11/9/2021, answer due 11/30/2021. (Dellinger, Megan) |
| Nov 10, 2021 | 8 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. Aurobindo Pharma Ltd. served on 11/9/2021, answer due 11/30/2021. (Dellinger, Megan) |
| Oct 27, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:21-cv-01485-CFC, 1:21-cv-01486-CFC, 1:21-cv-01487-CFC (rjb) |
| Oct 22, 2021 | 1 | Complaint* (1) |
| Oct 22, 2021 | 7 | Summons Issued (2) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Aurobindo Pharma Ltd. on 10/22/2021. (twk) |
| Oct 22, 2021 | 6 | Summons Issued (2) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Aurobindo Pharma USA, Inc. on 10/22/2021. (twk) |
| Oct 22, 2021 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C. H. Boehringer Sohn AG & Co. KG for Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (twk) |
| Oct 22, 2021 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,090,323 B2. (twk) |
| Oct 22, 2021 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: Not earlier than October 8, 2021. Date of Expiration of Patent: April 3, 2034. (twk) |
| Oct 22, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk) |
| Oct 22, 2021 | 1 | Civil Cover Sheet (1) |
| Oct 22, 2021 | 1 | Exhibit A (52) |
| Oct 22, 2021 | 1 | Main Document (24) Docket Text: COMPLAINT filed against Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3727443.) - filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(twk) |
